Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"
23/02/24 Institute of Biomedical Research Corp. Introduces M2BioKids CI
29/01/24 Real American Capital Corp. acquired M2MMA from Institute of Biomedical Research Corp.. CI
12/10/23 Institute of Biomedical Research Corp. Appoints Victor Lange as CEO of M2MMA CI
20/09/23 Institute of Biomedical Research Corp. acquired JDAX. CI
13/09/23 Institute of Biomedical Research Corp. Presents Update on its Latest Scientific Endeavor: M2Bio Sciences Endeavors to Usher in a Paradigm Shift Within the Realm of Medical Health by Focusing on the Foundational Facet of Drug Discovery CI
13/09/23 Institute of Biomedical Research Corp. Appoints Ze-Ev Krein, an Interdisciplinary Scientist, and M2bio Scientific Advisory Board Chairman CI
17/07/23 Institute of Biomedical Research Corp. Unveils a Line of Purple, White, and Green Teas from Kenya, Exhibiting Numerous Medicinal Health Benefits CI
26/06/23 Institute of Biomedical Research Corp. signed a letter of intent to acquire JDAX. CI
16/06/23 Institute of Biomedical Research Corp. Establishes Research Chair At the University of Pretoria for Phytomedicines CI
17/07/22 Institute of Biomedical Research Corp. agreed to acquire Biomedical and Nutraceutical Assets of Wuhan General Group, Inc. (OTCPK : WUHN). CI
27/01/15 Institute of Biomedical Research Corp. acquired Travel Mix Group Inc. CI
28/04/14 Neuro-Biotech Corp. will Change its Name to The Institute of Biomedical Research Corp CI
31/01/14 Institute of Biomedical Research acquired Neuro-Biotech Corp. in a reverse merger transaction. CI
1 day+18.18%
1 week+18.18%
Current month-23.53%
1 month-23.53%
6 months-63.89%
Current year-53.57%
1 week 0
Extreme 0.0009
0
1 month 0
Extreme 0.0009
0
Current year 0
Extreme 0.0007
0.01
1 year 0
Extreme 0.0007
0.02
3 years 0
Extreme 0.0001
0.03
5 years 0
Extreme 0.0001
0.04
10 years 0
Extreme 0.0001
0.04
Manager TitleAgeSince
Chief Executive Officer - 10/07/2022
Director of Finance/CFO 68 -
Chief Tech/Sci/R&D Officer - 24/11/2024
Director TitleAgeSince
Director/Board Member - 10/07/2022
Director/Board Member 68 -
Date Price Change Volume
22/06/26 US$0.001300 +18.18% 3,489,408
18/06/26 US$0.001100 -15.38% 21,300
17/06/26 US$0.001300 +18.18% 2,634,058
  1. Stock Market
  2. Stocks
  3. MRES Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!